Clover Health is trading 5.33% down at $4.36 after no clear company-specific catalyst emerged for the August 17, 2026 decline.
- The latest verified company update was its August 5 earnings report, which showed strong second-quarter results and improved full-year guidance, rather than negative news.
- The broader market is only modestly lower, so market-wide weakness does not clearly explain the move.
- Volume information was unavailable, leaving the cause uncertain.